Home Cart 0 Sign in  
X

[ CAS No. 1352625-27-4 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 1352625-27-4
Chemical Structure| 1352625-27-4
Chemical Structure| 1352625-27-4
Structure of 1352625-27-4 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 1352625-27-4 ]

Related Doc. of [ 1352625-27-4 ]

Alternatived Products of [ 1352625-27-4 ]

Product Details of [ 1352625-27-4 ]

CAS No. :1352625-27-4 MDL No. :N/A
Formula : C10H9FN2O2 Boiling Point : -
Linear Structure Formula :- InChI Key :ZLZKMWIDSKGQON-UHFFFAOYSA-N
M.W :208.19 Pubchem ID :66980566
Synonyms :

Calculated chemistry of [ 1352625-27-4 ]

Physicochemical Properties

Num. heavy atoms : 15
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.2
Num. rotatable bonds : 3
Num. H-bond acceptors : 4.0
Num. H-bond donors : 0.0
Molar Refractivity : 51.24
TPSA : 43.6 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -6.59 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.33
Log Po/w (XLOGP3) : 1.38
Log Po/w (WLOGP) : 2.07
Log Po/w (MLOGP) : 2.03
Log Po/w (SILICOS-IT) : 1.51
Consensus Log Po/w : 1.86

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.25
Solubility : 1.18 mg/ml ; 0.00567 mol/l
Class : Soluble
Log S (Ali) : -1.9
Solubility : 2.63 mg/ml ; 0.0126 mol/l
Class : Very soluble
Log S (SILICOS-IT) : -2.85
Solubility : 0.293 mg/ml ; 0.00141 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.94

Safety of [ 1352625-27-4 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 1352625-27-4 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 1352625-27-4 ]
  • Downstream synthetic route of [ 1352625-27-4 ]

[ 1352625-27-4 ] Synthesis Path-Upstream   1~3

  • 1
  • [ 1352625-27-4 ]
  • [ 1352625-29-6 ]
Reference: [1] Patent: WO2012/45729, 2012, A1, . Location in patent: Page/Page column 27-28
  • 2
  • [ 623-47-2 ]
  • [ 1352625-28-5 ]
  • [ 1352625-27-4 ]
Reference: [1] Patent: WO2012/45729, 2012, A1, . Location in patent: Page/Page column 27
  • 3
  • [ 372-47-4 ]
  • [ 1352625-27-4 ]
Reference: [1] Patent: WO2012/45729, 2012, A1,
Same Skeleton Products
Historical Records

Related Parent Nucleus of
[ 1352625-27-4 ]

Pyrazoles

Chemical Structure| 1352625-28-5

[ 1352625-28-5 ]

Ethyl 4-fluoropyrazolo[1,5-a]pyridine-3-carboxylate

Similarity: 0.97

Chemical Structure| 2177264-85-4

[ 2177264-85-4 ]

Ethyl 4-bromo-6-fluoropyrazolo[1,5-a]pyridine-3-carboxylate

Similarity: 0.86

Pyridines

Chemical Structure| 1352625-28-5

[ 1352625-28-5 ]

Ethyl 4-fluoropyrazolo[1,5-a]pyridine-3-carboxylate

Similarity: 0.97

Chemical Structure| 2177264-85-4

[ 2177264-85-4 ]

Ethyl 4-bromo-6-fluoropyrazolo[1,5-a]pyridine-3-carboxylate

Similarity: 0.86